Advertisement

AMED

Amedisys, Inc.

Healthcare

Set alert

Price alert · AMED

All alert types
100.99 0.00 0.00%
As of Aug 14, 2025
100.93 Day range 101.02
82.15 52-week range 101.02
YTD
+11.23%
1 year
+3.24%
Open
101.00
Prev close
100.99
Mkt cap
3.32B
Vol
1.04M
Avg vol
549.55K
EPS
2.57
P/E
39.30
Div yield
0.00%
More statistics
Low
100.93
High
101.02
Forward P/E
19.76
Beta
0.90
Short ratio
6.84
Inst. own
96.37%
Dividend
0.00
Ex-div date
Earnings
Jul 29, 2025
50-d avg
98.01
200-d avg
93.25
1y target
0.00

2Y chart

Chart tools
Interval
AMED two-year price chart82.286.991.696.3101.0Aug 23Jan 24Jun 24Oct 24Mar 25Aug 25

Key statistics

Market cap
3.32B
Enterprise value
3.48B
Trailing P/E
39.30
Forward P/E
19.76
PEG ratio
0.00
Price / sales
1.38
Price / book
2.69
EPS (TTM)
2.57
Beta
0.90
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
3.56%
Revenue (TTM)
2.40B
Revenue growth
5.20%
Free cash flow
300.69M
Total cash
337.30M
Total debt
450.51M
Return on equity
6.67%
Shares outstanding
32.89M
Short % of float
9.90%
50-day average
98.01
200-day average
93.25

Analyst view

Consensus: hold

Hold
Price target (mean) 0.00
Ratings (0m) 6 1 buy · 4 hold · 1 sell
  • Strong buy1
  • Buy0
  • Hold4
  • Sell1
  • Strong sell0

Next earnings

Jul 29, 2025

Expected Jul 29, 2025. Consensus EPS estimate 1.20.

Earnings history

Financials — quick view

All financials
AMED Revenue — quarterly 621.86M
2021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 2025
AMED Net income — quarterly 28.08M
2021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 2025
AMED EPS — quarterly 0.85
2021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 2025

Earnings

AMED recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Jul 29, 2025Jun 1, 20251.39———
Apr 23, 2025Mar 1, 20251.13———
Feb 26, 2025Dec 1, 20241.05———
Nov 6, 2024Sep 1, 20241.14———
Jul 24, 2024Jun 1, 20241.22———
Apr 24, 2024Mar 1, 20241.01———

Upgrades / downgrades

AMED analyst upgrades and downgrades
DateFirmActionFromTo
Apr 16, 2025RBC CapitalreitOutperformOutperform
Mar 4, 2025Stephens & Co.reitEqual-WeightEqual-Weight
Feb 12, 2025Stephens & Co.reitEqual-WeightEqual-Weight
Jul 31, 2024Deutsche BankdownBuyHold
Jul 25, 2024Cantor FitzgeraldreitNeutralNeutral
Jul 1, 2024William BlairdownOutperformMarket Perform

About Amedisys, Inc.

Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was formerly known as Analytical Nursing Management Corp. and changed its name to Amedisys, Inc. in August 1995. The company was founded in 1982 and is headquartered in Baton Rouge, Louisiana with an additional office in Nashville, Tennessee. As of August 14, 2025, Amedisys, Inc. operates as a subsidiary of Optum, Inc.

Sector
Healthcare
Industry
Medical Care Facilities
Country
United States
Website
amedisys.com

News

Your note

Sign in to keep a note on AMED — it syncs with the Stock Master app.

Insider holders

AMED insider holders
InsiderRelationLatest transactionDateShares held
ASHWORTH RICHARD MChief Executive OfficerConversion of Exercise of derivative securityAug 13, 20250
BOHNERT DENISE M.OfficerConversion of Exercise of derivative securityAug 13, 20250
CAPPS VICKIE LYNNDirectorStock Award(Grant)May 1, 20259,818
COYE MOLLY JOELDirectorStock Award(Grant)May 1, 20258,818
GINN SCOTT GChief Financial OfficerConversion of Exercise of derivative securityAug 13, 20250
GUIDROZ ALLYSONOfficerStock Award(Grant)Aug 5, 20259,473

Institution ownership

AMED institution ownership
Holder% heldSharesValueReported
Blackrock Inc.10.17%3,345,633337.88MJun 29, 2025
Vanguard Group Inc9.25%3,041,392307.15MJun 29, 2025
Pentwater Capital Management Lp5.22%1,715,084173.21MJun 29, 2025
FIL LTD3.99%1,312,785132.58MJun 29, 2025
Alpine Associates Management Inc.3.34%1,096,920110.78MJun 29, 2025
State Street Corporation3.25%1,067,613107.82MJun 29, 2025

Fund ownership

AMED fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Mid-Cap ETF3.25%1,067,364107.79MJun 29, 2025
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.14%1,032,785104.30MMar 30, 2025
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.49%818,01882.61MMar 30, 2025
VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund1.61%529,66453.49MMar 30, 2025
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.53%504,31850.93MMar 30, 2025
CALAMOS INVESTMENT TRUST/IL-Calamos Market Neutral Income Fund1.50%492,43949.73MApr 29, 2025
Advertisement